Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Postpartum depression
MeSH D019052 - postpartum depression
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D011644:
Puerperal disorders
0 Companies
0 Drugs
Success rate
D003866:
Depressive disorder
168 Companies
36 Drugs
$
Success rate
D019052:
Postpartum depression
2 Companies
2 Drugs
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Biogen
Zuranolone
Zurzuvae
2034-04-17
2023-10-31
Sage Therapeutics
Brexanolone
Zulresso
2029-03-13
2019-06-17
Clinical Trials
Historical Success Rate
Phase 1
50
%
2/4
Phase 2
67
%
12/18
Phase 3
29
%
4/14
Approved:
1
Overall Success rate:
10%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Biogen
Zuranolone
Sage Therapeutics
Brexanolone
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use